2 wickedly good stocks to buy and hold forever

Time is on your side with quality stocks and the power of compounding.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Combining the elements of growth and income underpins a diversified portfolio. Your good stock ideas might take some time for the story to develop, so in the meantime you want to ensure you produce some income.

If you don't, you may get anxious about your returns and switch out of stocks too soon, short-circuiting your long-term investing goals.

Be patient in choosing the right stocks, then be even more patient in allowing them to grow.

So here are two buy and hold stocks in the S&P ASX 200 Index (ASX: ^XJO) that could give you that balance for building wealth.

1)  Coca-Cola Amatil Ltd (ASX: CCL)

Being the bottler and distributor of the world's most famous soft drink for Australia, New Zealand, Indonesia, Fiji and PNG, you would expect the company has business longevity. This one is more for steady dividend income. The stock yields a whopping 5.6% dividend.

The company has flagged an expected 15% earnings decrease, sending the well-admired stock downward about 20%. Long-term investors with noses for discounted prices could look past this short-term price depression and see it as a buying opportunity to begin or add to a position.

People will be drinking Coke and other soft or alcoholic beverages that it sells for many years to come. You can put your investment money to work over time with this stock.

2)  CSL Limited (ASX: CSL)

As a biopharmaceutical developing treatments for blood related disorders and viral/bacterial diseases, high demand for CSL's specialised medical products drives long-term growth and builds a protective "moat" around the company's business.

The $32 billion company's stock offers a 1.8% dividend yield. However, it ploughs a majority of its earnings back into the company to sustain its expansion, research and development. The pace at which its earnings and dividends have grown in the past gives investors good hopes for future investment growth.

Coming off a fantastic 2013 when earnings were up 38%, some analysts forecast earnings to rise an average 15% annually over the next several years. This growth stock is a good choice for powering your portfolio returns in the long run.

Motley Fool contributor Darryl Daté-Shappard does not own shares in any company mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »